Sweden · Delayed Price · Currency is SEK Ascelia Pharma AB Statistics
Total Valuation
STO:ACE has a market cap or net worth of SEK 83.59 million. The enterprise value is 46.04 million.
| Market Cap | 83.59M |
| Enterprise Value | 46.04M |
Important Dates
The last earnings date was Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:ACE has 133.54 million shares outstanding. The number of shares has increased by 41.53% in one year.
| Current Share Class | 133.54M |
| Shares Outstanding | 133.54M |
| Shares Change (YoY) | +41.53% |
| Shares Change (QoQ) | +3.98% |
| Owned by Insiders (%) | 5.39% |
| Owned by Institutions (%) | 25.89% |
| Float | 123.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.93 |
| P/TBV Ratio | 2.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.11, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.11 |
| Quick Ratio | 4.01 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | -51.70 |
Financial Efficiency
Return on equity (ROE) is -65.52% and return on invested capital (ROIC) is -38.63%.
| Return on Equity (ROE) | -65.52% |
| Return on Assets (ROA) | -32.92% |
| Return on Invested Capital (ROIC) | -38.63% |
| Return on Capital Employed (ROCE) | -66.11% |
| Weighted Average Cost of Capital (WACC) | 9.87% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -6.01M |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -112,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.61% in the last 52 weeks. The beta is 0.84, so STO:ACE's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -86.61% |
| 50-Day Moving Average | 1.12 |
| 200-Day Moving Average | 2.51 |
| Relative Strength Index (RSI) | 39.74 |
| Average Volume (20 Days) | 1,090,987 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -59.41M |
| Pretax Income | -60.24M |
| Net Income | -60.13M |
| EBITDA | -59.41M |
| EBIT | -59.41M |
| Earnings Per Share (EPS) | -0.48 |
Balance Sheet
The company has 38.05 million in cash and 490,000 in debt, with a net cash position of 37.56 million or 0.28 per share.
| Cash & Cash Equivalents | 38.05M |
| Total Debt | 490,000 |
| Net Cash | 37.56M |
| Net Cash Per Share | 0.28 |
| Equity (Book Value) | 89.83M |
| Book Value Per Share | 0.68 |
| Working Capital | 32.30M |
Cash Flow
| Operating Cash Flow | -67.19M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | -5,500 |
| Net Borrowing | -813,000 |
| Free Cash Flow | -67.19M |
| FCF Per Share | -0.50 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:ACE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -41.53% |
| Shareholder Yield | -41.53% |
| Earnings Yield | -71.93% |
| FCF Yield | -80.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |